Laboratorios Bagó S.A.
Laboratorios Bagó S.A., a prominent player in the pharmaceutical industry, is headquartered in Argentina (AR) and operates extensively across Latin America and beyond. Founded in 1934, the company has established itself as a leader in the development and manufacturing of high-quality medications, particularly in the fields of cardiology, oncology, and infectious diseases. With a diverse portfolio that includes prescription drugs, over-the-counter products, and innovative biopharmaceuticals, Laboratorios Bagó is recognised for its commitment to research and development. The company’s unique approach to product formulation and quality assurance has earned it a strong market position, making it a trusted name among healthcare professionals and patients alike. Notable achievements include significant contributions to public health initiatives and a robust presence in both domestic and international markets.
DitchCarbon Score
How does Laboratorios Bagó S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laboratorios Bagó S.A.'s score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laboratorios Bagó S.A.'s reported carbon emissions
Laboratorios Bagó S.A., headquartered in Argentina, currently does not have publicly available data regarding its carbon emissions. As of now, there are no specific figures detailing their Scope 1, 2, or 3 emissions, nor have they outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi). In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This includes efforts to reduce their carbon footprint and enhance environmental responsibility. Laboratorios Bagó S.A. may be engaging in similar initiatives, although specific details are not provided. As the industry evolves, stakeholders are encouraged to monitor the company's future disclosures regarding its climate strategies and emissions data.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laboratorios Bagó S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
